AmicoMed

Industry: IT Services, Health and Welfare, Healthcare

Reference Market: US, EU

Inflow: MI2020 NewYork2018, MI2020 London2018

Total capital raised so far: €1.200K

Website: www.amicomed.us

Key person infos

Nome Cognome: Giangiacomo Rocco di Torrepadula

Ruolo: CEO & Co-Founder

Email: support@amicomed.com

Overview

Amicomed is a cloud-based platform to support physicians in BP management.

The platform combines innovative remote monitoring, through unprecedented data analysis, with an actionable and personalized lifestyle intervention (daily diet, activity, and BP measurement scheduling).

The service is fully automated thanks to proprietary algorithms. Aimed at physicians, yet designed with consumer in mind. Use cases are all conditions in which BP must be kept under control (e.g. Hypertension, CHF and pregnancy).

The outcomes are striking: a reduction of mean systolic BP of 5mmHg (up to 20) with an adherence of 70%. According to clinical literature, a mean systolic reduction of 5mmHg reduces mortality by 30% and leads to $24bln savings in the US alone. Results have been peer reviewed and presented to latest ACC, ASH, ESH, and ISH.